As expected, the excessive MMP-9 levels in the brains of AD mice were significantly reduced by OT administration, suggesting that the inhibition of AQP4 depolarization by OT is likely to be achieved by blocking the MMP-9/β-DG/AQP4 pathways. Here, AQP4 is linked to Alzheimer disease.